Clinical Trials Browser

Phase 3 × Unknown × lanreotide × Clear all

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma